FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080163 [Registered on: 10/02/2025] Trial Registered Prospectively
Last Modified On: 06/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A CLINICAL STUDY TO SEE DIFFERENCE BETWEEN EFFECT OF KAISORA GUGGULU WITH MANJISTHADI KWATH AND EKAVINASATIKO GUGGULU WITH NISHADI KWATH IN THE MANAGEMENT OF PSORIASIS 
Scientific Title of Study   A CLINICO-COMPARATIVE STUDY OF KAISORA GUGGULU WITH MANJISTHADI KVATHA AND EKAVINSATIKO GUGGULU WITH NISADI KVATHA IN THE MANAGEMENT OF PSORIASIS 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Manali Chauhan 
Designation  2nd Year PG Scholar 
Affiliation  J.S Ayurveda 
Address  Post Graduate Department of kaya chikitsa, J.S. Ayurveda Mahavidyalaya, College Road, Nadiad, Kheda, Gujrat

Kheda
GUJARAT
387001
India 
Phone  9512773334  
Fax    
Email  chauhanmanali1999@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr Manish Patel 
Designation  Professor and HOD 
Affiliation  J S Ayurveda Mahavidyalaya and P D Patel Ayurvedic Hospital Nadiad 
Address  Post Graduate Department of kaya chikitsa, J.S. Ayurveda Mahavidyalaya, College Road, Nadiad, Kheda, Gujrat

Kheda
GUJARAT
387001
India 
Phone  9979589865  
Fax    
Email  manishayu97@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Prof Dr Manish Patel 
Designation  Professor and HOD 
Affiliation  J S Ayurveda Mahavidyalaya and P D Patel Ayurvedic Hospital Nadiad 
Address  Post Graduate Department of kaya chikitsa, J.S. Ayurveda Mahavidyalaya, College Road, Nadiad, Kheda, Gujrat


GUJARAT
387001
India 
Phone  9979589865  
Fax    
Email  manishayu97@yahoo.com  
 
Source of Monetary or Material Support  
Sundar Ayurveda pharmacy, J S Ayurveda Mahavidyalaya and P D Patel Ayurvedic Hospital,Collage road Nadiad, kheda,Gujrat 387001 
 
Primary Sponsor  
Name  J S Ayurveda Mahavidyalaya  
Address  J S Ayurveda Mahavidyalaya,Collage road,Nadiad 387001 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
J S Ayurveda Mahavidyalaya   J S Ayurveda Mahavidyalaya,Collage road,Nadiad 387001 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Manali  P D Patel Ayurveda Hospital  Post Graduate Department of Kayachikitsa, J.S. Ayurveda Mahavidyalaya and P D Patel Ayurvedic hospital, College Road, Nadiad, Kheda, Gujrat
Kheda
GUJARAT 
9512773334

chauhanmanali1999@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee for Human Research   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L409||Psoriasis, unspecified. Ayurveda Condition: KUSHTHAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Manjisthadi kwath, Reference: Sharangadhara samhita by Dr. rahmanand Tripathi, Sharangadhara. Varanasi: Chaukhambha Surbharati Prakashana; 2017.Sharangadhara Samhita Madhyam Khanda, Kvathadi Kalpana 2/136-142, p. 102, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 20(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 8 Weeks, anupAna/sahapAna: No, Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Kaisora Guggulu, Reference: Shrangadhara samhita by Dr. rahmanand Tripathi, Sharangadhara. Varanasi: Chaukhambha Surbharati Prakashana; 2017.Sharangadhara Samhita Madhyam Khanda, Vataka Kalpana; 7/70- 81, p. 136 , Route: Oral, Dosage Form: Guggulu , Dose: 900(mg), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 8 Weeks, anupAna/sahapAna: Yes(details: jala), Additional Information: -
3Intervention ArmDrugClassical(1) Medicine Name: Ekavinsatiko guggulu, Reference: Yogaratnakara “vidhyotini tika” by Vaidhya Shreelaxmipatishashtri, Chow khamba Sanskrit series office, varanasi, India; kushtha Adhyay/1-5, p. 222, Route: Oral, Dosage Form: Guggulu , Dose: 900(mg), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 8 Weeks, anupAna/sahapAna: Yes(details: jala), Additional Information: -
4Intervention ArmDrugClassical(1) Medicine Name: Nishadi kwath , Reference: Ashtag Hridayam by Dr. ramhanand Tripathi, Chow khamba Sanskrit series office, varanasi, India , kushtha chikitsa 19/38 , p. 788, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 20(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 8 Weeks, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Who fulfilled the diagnostic criteria mentioned as sign and symptom
Any three of these symptoms
1.Scaling
2.Itching (Kandu)
3.Erythema
4.Loss of perspiration
5.Dryness
Any one of these signs
1.Auspitz sign
2.Candle grease sign
3.Koebners phenomenon
Patients of age between 18 to 60 years and of both genders. 
 
ExclusionCriteria 
Details  Pregnant or lactating females.
1.Known cases of diseases like AIDS, STD, TB, heart diseases and other disorders that lead to fetal conditions for the patients.
2.Patients having diabetes mellitus.
3.Other concomitant skin diseases occurring with the allergic reaction of any other disease. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To observe and find out changes in signs and symptoms of psoriasis after the oral administration of above mentioned medicinnes   A patient will be treated at O.P.D. level for 8 weeks of treatment. They will be instructed to visit the hospital every 2 weeks at intervals. 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the changes in the PASI index in the patients of psoriasis.
2.To find out the improvement in quality of life through changes in DLQI in the patients of psoriasis. 
A patient will be treated at O.P.D. level for 8 weeks of treatment. They will be instructed to visit the hospital every 2 weeks at intervals. 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Psoriasis is a complex, chronic, multifactorial, inflammatory disease that
involves hyper proliferation of keratinocytes in the epidermis, with an
increase in the epidermal cell turnover rate. 20 patient of psoriasis who
fulfill the inclusion criteria will be selected from opd and give them oral
administration of khadirastak kwatha 40 ml twice a day and manjisthadi
taila for local application twice a day. Patient will be treated for 8 weeks.
Patients will be assessed before and after the treatment.
 
Close